[Mitoxantrone HCl (1,4-dihydroxy-4, 8-bis[[2-(hydroxyethyl)-amino-ethyl)]amino 9,10-anthracenedione dihydrochloride (NSC 301739) - a new cytostatic]. - Suppr

Suppr

超能文献

[Mitoxantrone HCl (1,4-dihydroxy-4, 8-bis[[2-(hydroxyethyl)-amino-ethyl)]amino 9,10-anthracenedione dihydrochloride (NSC 301739) - a new cytostatic].

作者信息

Hagenberg L, Loynds P, Nagel G A

出版信息

Onkologie. 1980 Dec;3(6):322-8. doi: 10.1159/000214816.

DOI:10.1159/000214816

PMID:6784060

Abstract

摘要

相似文献

[Mitoxantrone HCl (1,4-dihydroxy-4, 8-bis[[2-(hydroxyethyl)-amino-ethyl)]amino 9,10-anthracenedione dihydrochloride (NSC 301739) - a new cytostatic].

Onkologie. 1980 Dec;3(6):322-8. doi: 10.1159/000214816.

Phase I clinical investigation of 1,4-dihydroxy-5,8-bis (( (2-[(2-hydroxyethyl)amino]ethyl) amino))-9,10-anthracenedione dihydrochloride (NSC 301739), a new anthracenedione.

Cancer Res. 1980 May;40(5):1516-8.

Phase I clinical trial f mitoxantrone: a new anthracenedione anticancer drug.

Cancer Chemother Pharmacol. 1980;5(1):11-5. doi: 10.1007/BF00578556.

Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice.

Cancer Res. 1979 May;39(5):1570-4.

Phase II trial of 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino 9,10-anthracenedione dihydrochloride)(NSC 301739, DHAD) in patients with metastatic malignant melanoma. A Southwest Oncology Group pilot.

Invest New Drugs. 1985;3(1):67-9. doi: 10.1007/BF00176827.

Phase II trial of mitoxantrone in head and neck cancer.

Invest New Drugs. 1984;2(3):329-30. doi: 10.1007/BF00175386.

Clinical kinetics of 1, 4-dihydroxy-5,8-bis [(2-[(2-hydroxyethyl) amino] ethyl] amino ]-9, 10-anthracenedione.

Clin Pharmacol Ther. 1982 Mar;31(3):312-6. doi: 10.1038/clpt.1982.39.

Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acids.

Biochem Pharmacol. 1981 Feb 1;30(3):231-40. doi: 10.1016/0006-2952(81)90083-6.

Biologic and biochemical effects of mitoxantrone.

Semin Oncol. 1984 Sep;11(3 Suppl 1):3-10.

Structure-activity relationship study of anthraquinones: 1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethoxy)ethyl]amino]-9,10-anthracenedione, an analog of an established antineoplastic agent.

J Pharm Sci. 1982 Jun;71(6):708-9. doi: 10.1002/jps.2600710626.

引用本文的文献

Mitoxantrone: an active new agent in the treatment of advanced breast cancer.

Cancer Chemother Pharmacol. 1984;12(1):1-4. doi: 10.1007/BF00255899.

First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer.

Invest New Drugs. 1985;3(2):167-71. doi: 10.1007/BF00174165.

Mitoxantrone as a first-line treatment of advanced breast cancer.

Invest New Drugs. 1985;3(2):133-7. doi: 10.1007/BF00174160.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验